Nevertheless, following the progression of TAM metabolic mechanism research, it has been shown that being the activation product of TAM, endoxifen has high activity to inhibit the growth of tumor by competitive binding of ER with estradiol and blocking estrogenic effect. Here, ESR1 is linked to neoplasm.